Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Is McKesson Stock Underperforming the S&P 500?

McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products. With a market cap of $65.7 billion, the company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytics, care management, and patient solutions for payers.

Companies worth $10 billion or more are generally described as “large-cap stocks.” MCK effortlessly fits that category. McKesson is a leading player in U.S. pharmaceutical distribution, supported by a vast network and broad product range. Its diversified services, spanning drug distribution, medical-surgical supplies, and technology solutions, provide multiple revenue streams and help reduce dependency on any single business segment.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.